Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 4
2022 8
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Geography of hospital admissions for multiple sclerosis in Greece.
Dadouli K, Ntellas P, Anagnostopoulos L, Bonotis K, Dardiotis E, Hadjichristodoulou C. Dadouli K, et al. Among authors: anagnostopoulos l. Mult Scler Relat Disord. 2021 Apr;49:102735. doi: 10.1016/j.msard.2021.102735. Epub 2021 Jan 5. Mult Scler Relat Disord. 2021. PMID: 33444957
MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19.
Speletas M, Dadouli K, Syrakouli A, Gatselis N, Germanidis G, Mouchtouri VA, Koulas I, Samakidou A, Nikolaidou A, Stefos A, Mimtsoudis I, Hatzianastasiou S, Koureas M, Anagnostopoulos L, Tseroni M, Tsinti G, Metallidis S, Dalekos G, Hadjichristodoulou C. Speletas M, et al. Among authors: anagnostopoulos l. Immunobiology. 2021 Nov;226(6):152136. doi: 10.1016/j.imbio.2021.152136. Epub 2021 Sep 24. Immunobiology. 2021. PMID: 34628288 Free PMC article.
The rs1883832 Polymorphism (CD40-1C>T) Affects the Intensity of IgA Responses after BNT162b2 Vaccination.
Speletas M, Bakaros E, Peristeri AM, Voulgaridi I, Sarrou S, Paliatsa V, Nasika A, Tseroni M, Anagnostopoulos L, Theodoridou K, Kalala F, Theodoridou A, Mouchtouri BA, Tsiodras S, Eibel H, Hadjichristodoulou C. Speletas M, et al. Among authors: anagnostopoulos l. Int J Mol Sci. 2022 Nov 14;23(22):14056. doi: 10.3390/ijms232214056. Int J Mol Sci. 2022. PMID: 36430533 Free PMC article.
Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Different States of Bipolar Disorder.
Dadouli K, Janho MB, Hatziefthimiou A, Voulgaridi I, Piaha K, Anagnostopoulos L, Ntellas P, Mouchtouri VA, Bonotis K, Christodoulou N, Speletas M, Hadjichristodoulou C. Dadouli K, et al. Among authors: anagnostopoulos l. Brain Sci. 2022 Aug 4;12(8):1034. doi: 10.3390/brainsci12081034. Brain Sci. 2022. PMID: 36009097 Free PMC article.
Repeated Leftover Serosurvey of SARS-CoV-2 IgG Antibodies in Greece, May to August 2020.
Bogogiannidou Z, Speletas M, Vontas A, Nikoulis DJ, Dadouli K, Kyritsi MA, Mouchtouri VA, Mina P, Anagnostopoulos L, Koureas M, Karavasilis V, Nikou O, Pinaka O, Thomaidis PC, Kadoglou K, Bedevis K, Spyrou N, Eleftheriou AA, Papaevangelou V, Gikas A, Vatopoulos A, Ntzani EE, Prezerakos P, Tsiodras S, Hadjichristodoulou C. Bogogiannidou Z, et al. Among authors: anagnostopoulos l. Vaccines (Basel). 2021 May 13;9(5):504. doi: 10.3390/vaccines9050504. Vaccines (Basel). 2021. PMID: 34068100 Free PMC article.
SARS-CoV-2 Sero-Surveillance in Greece: Evolution over Time and Epidemiological Attributes during the Pre-Vaccination Pandemic Era.
Koureas M, Bogogiannidou Z, Vontas A, Kyritsi MA, Mouchtouri VA, Dadouli K, Anagnostopoulos L, Mina P, Matziri A, Ntouska M, Tsigaridaki M, Gkiata V, Tsilidis KK, Ntzani EE, Prezerakos P, Tsiodras S, Speletas M, Hadjichristodoulou C. Koureas M, et al. Among authors: anagnostopoulos l. Diagnostics (Basel). 2022 Jan 25;12(2):295. doi: 10.3390/diagnostics12020295. Diagnostics (Basel). 2022. PMID: 35204386 Free PMC article.
Behavioral and Cultural Insights, a Nationwide Study Based on Repetitive Surveys of WHO Behavioral Insights Tool in Greece Regarding COVID-19 Pandemic and Vaccine Acceptance.
Prezerakos P, Dadouli K, Agapidaki E, Kravvari CM, Avakian I, Peristeri AM, Anagnostopoulos L, Mouchtouri VA, Fountoulakis KN, Koupidis S, Hadjichristodoulou C. Prezerakos P, et al. Among authors: anagnostopoulos l. Int J Environ Res Public Health. 2022 Dec 23;20(1):216. doi: 10.3390/ijerph20010216. Int J Environ Res Public Health. 2022. PMID: 36612538 Free PMC article.
Intensity and Dynamics of Anti-SARS-CoV-2 Immune Responses after BNT162b2 mRNA Vaccination: Implications for Public Health Vaccination Strategies.
Speletas M, Voulgaridi I, Sarrou S, Dadouli A, Mouchtouri VA, Nikoulis DJ, Tsakona M, Kyritsi MA, Peristeri AM, Avakian I, Nasika A, Fragkou PC, Moschopoulos CD, Zoubouneli S, Onoufriadis I, Anagnostopoulos L, Matziri A, Papadamou G, Theodoridou A, Tsiodras S, Hadjichristodoulou C. Speletas M, et al. Among authors: anagnostopoulos l. Vaccines (Basel). 2022 Feb 17;10(2):316. doi: 10.3390/vaccines10020316. Vaccines (Basel). 2022. PMID: 35214774 Free PMC article.
Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines.
Voulgaridi I, Sarrou S, Dadouli A, Peristeri AM, Nasika A, Onoufriadis I, Kyritsi MA, Anagnostopoulos L, Theodoridou A, Avakian I, Pappa D, Konstantinou AK, Papadamou G, Mouchtouri VA, Petinaki E, Speletas M, Hadjichristodoulou C. Voulgaridi I, et al. Among authors: anagnostopoulos l. Vaccines (Basel). 2022 Aug 6;10(8):1268. doi: 10.3390/vaccines10081268. Vaccines (Basel). 2022. PMID: 36016156 Free PMC article.
15 results